2[1]Peter H, Katrin I, Oliver T, et al. Acid- base balance and substitution fluid during continuous hemofiltration. Kidney Int, 1999, 56(suppl 72): S37 - S40
3[2]Kunstle T, Maulhardt S, Grunberger M, et al. Heparin - induced thrombocytopenia and hemofiltration: regional anticoagulation with sodium citrate. Anasthesiol Intensivmed Notfallmed Schmerzther,2000, 35(2): 115 - 118
4[3]Sramek V, Novak I, Matejovic M, et al. Continuous venovenous hemodiafiltration (CVVHDF) with citrate anticoagulation in the treatment of a patient with acute renal failure, hypercalcemia, and thrombocytopenia. Intensive Care Med, 1998, 24(3): 262 - 264
5[4]Kutsogiannis DJ, Mayers I, Chin WD, et al. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis, 2000, 35(5): 802 -811
6[5]Clark WR, Hamburger RJ, Lysaght MJ. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis. Kidney Int, 1999, 56(6): 2005-2015
7[6]Martien J. F. M, Jeroen K. D, Theodoor H. K, et al. Citrate compared to low molecular weight hepatin anticoagulation in chronic hemodialysis patients. Kidney Int, 1996, 49: 806- 813
8[8]Kunstle T, Maulhardt S, Grunberger M, et al. Heparin - induced thrombocytopenia and hemofiltration: regional anticoagulation with sodium citrate. Kidney Int, 1996, 49: 806- 813
9[9]Oberbauer R, Fabrizii V, Druml W, et al. Acute acid - base disorder during plasma immunoadsorption treatment using citrate anticoagulation. Nephrol Dial Transplant, 1998, 13(6): 1581 - 1582
10Apsner R, Buchmayer H, Lang T,et al. Simplified citrate anticoagulation for high-flux hemodialysis. Am J Kidney Dis, 2001,38 ( 5 ):979-987.
